FDA's Stellar Review Performance Is Straining Workforce
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA is breaking records with approval numbers and review efficiency, but it comes with a cost: workforce strain is pervasive, OND's Jenkins tells FDA/CMS Summit.